David W Zaas
Overview
Explore the profile of David W Zaas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bain J, Turner D, Rehder K, Eisenstein E, Davis R, Cheifetz I, et al.
Respir Care
. 2015 Aug;
61(1):1-7.
PMID: 26264415
Background: An increasing number of centers are using active rehabilitation and ambulation for critically ill patients on extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation. This investigation assessed...
2.
Lehr C, Zaas D, Cheifetz I, Turner D
Chest
. 2015 May;
147(5):1213-1218.
PMID: 25940249
The proportion of critically ill patients awaiting lung transplantation has increased since the implementation of the Lung Allocation Score (LAS) in 2005. Critically ill patients comprise a sizable proportion of...
3.
Szabolcs P, Buckley R, Davis R, Moffet J, Voynow J, Antony J, et al.
J Allergy Clin Immunol
. 2014 Sep;
135(2):567-70.
PMID: 25262460
No abstract available.
4.
Hsia B, Pastva A, Giamberardino C, Potts-Kant E, Foster W, Que L, et al.
J Allergy Ther
. 2013 Nov;
Suppl 1(4).
PMID: 24273688
Background: Caveolin-1, the hallmark protein of caveolae, is highly expressed within the lung in the epithelium, endothelium, and in immune cells. In addition to its classical roles in cholesterol metabolism...
5.
Snyder L, Wang Z, Chen D, Reinsmoen N, Finlen-Copeland C, Davis W, et al.
Chest
. 2013 Jan;
144(1):226-233.
PMID: 23328795
Background: Long-term survival after lung transplant is limited by the development of chronic and progressive airflow obstruction, a condition known as bronchiolitis obliterans syndrome (BOS). While prior studies strongly implicate...
6.
Peppercorn J, Armstrong A, Zaas D, George D
Urol Oncol
. 2012 Feb;
31(7):1079-84.
PMID: 22305627
Objectives: As complex novel cancer drugs are developed, supply may transiently fail to meet demand as production capacity established for research purposes is scaled up to meet anticipated clinical volume....
7.
Lease E, Zaas D
Curr Opin Pulm Med
. 2011 Feb;
17(3):206-9.
PMID: 21326099
Purpose Of Review: Lung transplantation is an important therapeutic treatment for many patients with life-threatening pulmonary diseases; however, long-term survival is still relatively limited compared with other solid organ transplants....
8.
Hartwig M, Snyder L, Finlen-Copeland A, Lin S, Zaas D, Davis R, et al.
Clin Transpl
. 2010 Jun;
:197-210.
PMID: 20524285
Clinical lung transplantation continues to grow worldwide. Advances in donor selection and management have been critical to support the expanded growth of lung transplant as a therapeutic option for patients...
9.
Finlen Copeland C, Snyder L, Zaas D, Turbyfill W, Davis W, Palmer S
Am J Respir Crit Care Med
. 2010 May;
182(6):784-9.
PMID: 20508211
Rationale: Despite the importance of bronchiolitis obliterans syndrome (BOS) in lung transplantation, little is known regarding the factors that influence survival after the onset of this condition, particularly among bilateral...
10.
Lease E, Zaas D
Semin Respir Crit Care Med
. 2010 Apr;
31(2):234-42.
PMID: 20354935
Infections complications following lung transplantation are associated with significant morbidity and mortality. Management of infections is most challenging in patients with cystic fibrosis (CF), but all lung transplant recipients are...